Results
|
16721.
|
|
|
16722.
|
|
|
16723.
|
|
|
16724.
|
The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer. [electronic resource] by
- Prensner, John R
- Sahu, Anirban
- Iyer, Matthew K
- Malik, Rohit
- Chandler, Benjamin
- Asangani, Irfan A
- Poliakov, Anton
- Vergara, Ismael A
- Alshalalfa, Mohammed
- Jenkins, Robert B
- Davicioni, Elai
- Feng, Felix Y
- Chinnaiyan, Arul M
Producer: 20150122
In:
Oncotarget vol. 5
Availability: No items available.
|
|
16725.
|
The analysis of serum response factor expression in bone and soft tissue prostate cancer metastases. [electronic resource] by
- O'Hurley, Gillian
- Prencipe, Maria
- Lundon, Dara
- O'Neill, Amanda
- Boyce, Susie
- O'Grady, Anthony
- Gallagher, William M
- Morrissey, Colm
- Kay, Elaine W
- Watson, R William G
Producer: 20140303
In:
The Prostate vol. 74
Availability: No items available.
|
|
16726.
|
|
|
16727.
|
A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study. [electronic resource] by
- Ross, Robert W
- Galsky, Matthew D
- Scher, Howard I
- Magidson, Jay
- Wassmann, Karl
- Lee, Gwo-Shu Mary
- Katz, Leah
- Subudhi, Sumit K
- Anand, Aseem
- Fleisher, Martin
- Kantoff, Philip W
- Oh, William K
Producer: 20130403
In:
The Lancet. Oncology vol. 13
Availability: No items available.
|
|
16728.
|
|
|
16729.
|
|
|
16730.
|
|
|
16731.
|
Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration-resistant prostate cancer patients treated with abiraterone. [electronic resource] by
- Fan, Liancheng
- Wang, Xiao
- Chi, Chenfei
- Wang, Yanqing
- Cai, Wen
- Shao, Xiaoguang
- Xu, Fan
- Pan, Jiahua
- Zhu, Yinjie
- Shangguan, Xun
- Xin, Zhixiang
- Hu, Jianian
- Xie, Shaowei
- Wang, Rui
- Zhou, Lixin
- Dong, Baijun
- Xue, Wei
Producer: 20170911
In:
The Prostate vol. 77
Availability: No items available.
|
|
16732.
|
|
|
16733.
|
Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression. [electronic resource] by
- Böttcher, R
- Henderson, D J P
- Dulla, K
- van Strijp, D
- Waanders, L F
- Tevz, G
- Lehman, M L
- Merkle, D
- van Leenders, G J L H
- Baillie, G S
- Jenster, G
- Houslay, M D
- Hoffmann, R
Producer: 20160303
In:
British journal of cancer vol. 113
Availability: No items available.
|
|
16734.
|
|
|
16735.
|
|
|
16736.
|
|
|
16737.
|
|
|
16738.
|
|
|
16739.
|
|
|
16740.
|
|